Archive: Cancer Genetic Testing at the Crossroads

676 views · Published 2 November 2018 · 57:26 · Indexed 14 November 2026

Channel: UW Video · 2018 · Education

Watch on YouTube

Genomic sequencing technologies have enabled increasing use of cancer genetic testing for both inherited cancer predisposition and somatic mutation profiling in tumors.  This presentation reviews interplay between germline and somatic findings in cancer genetic testing, with particular emphasis on new areas of clinical utility.  These new areas include germline testing of cancer predisposition genes to guide cancer treatment decisions, tumor DNA sequencing to rule out Lynch syndrome, and tumor DNA sequencing used to inform germline variant classification.

Colin C. Pritchard, MD, PhD
Associate Professor
Director of Clinical Diagnostics, Brotman Baty Institute for Precision Medicine
Co-Director, Genetics and Solid Tumors Laboratory
Head, Genetics Division
Dept. of Laboratory Medicine
University of Washington

10/17/18

http://depts.washington.edu/labweb/Education/ContEdu/
https://uw.edu/video
The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.

More from this channel